Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Liver cancer represents the fourth leading cause of cancer-associated death worldwide. The heterogeneity of its tumor microenvironment (TME) is a major contributing factor of metastasis, relapse, and drug resistance. Regrettably, late diagnosis makes most liver cancer patients ineligible for surgery...
Main Authors: | Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, Michela Anna Polidoro, Barbara Franceschini, Ana Lleo, Eduardo Bonavita, Matteo Donadon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/1/26 |
Similar Items
-
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
by: Xiurong Cai, et al.
Published: (2022-12-01) -
HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype
by: Xiaojing Du, et al.
Published: (2023-01-01) -
Senescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke
by: Blake Ouvrier, et al.
Published: (2024-02-01) -
Editorial: The predictive benefits of inflammatory markers in cancers of the liver
by: Gianluca Rompianesi, et al.
Published: (2024-03-01) -
Reduction in Lens Epithelial Cell Senescence Burden through Dasatinib Plus Quercetin or Rapamycin Alleviates D-Galactose-Induced Cataract Progression
by: Yinhao Wang, et al.
Published: (2022-12-01)